Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Turtle Creek. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD-5.9%
YTD-0.1%
Positioning StanceCONSTRUCTIVE
Market CapMid Cap
GeographyUS
Digest Analysis
Quick Take
"Normalizing interest rates and extreme mega-cap valuation disparities create a coiled-spring dynamic for cash-generative mid-cap platform acquirers over leveraged private equity buyers."
Executive Summary
Turtle Creek Equity Fund delivered a net return of -5.9% in the third quarter of 2026, bringing year-to-date net performance to -0.1%, while portfolio underlying business value expanded by 10% over the same year-to-date timeframe. The portfolio finished September with 30 holdings and 52% of capital concentrated in its top 10 positions. The fund's value-oriented strategy faced headwinds relative to momentum benchmarks as extreme capital concentration persisted in mega-cap technology and artificial intelligence names, though July demonstrated a sharp reversal where broadening market breadth allowed the strategy to outperform the U.S. MidCap index by 1,000 basis points.
The manager contextualizes rising long-term interest rates toward 5% not as a systemic crisis, but as a healthy normalization of the cost of capital following fifteen years of artificial quantitative easing. Higher debt costs disproportionately constrain leveraged private equity competitors, enhancing the competitive positioning of public platform companies that execute accretive tuck-in acquisitions. Additionally, the portfolio maintains minimal direct exposure to escalating U.S.-Canada cross-border tariffs, with less than 10% of revenue and earnings denominated in Canadian dollars.
Portfolio activity was marked by the addition of Patrick Industries following its announced all-stock merger with LCI Industries, capitalizing on short-term multiple compression. The manager opportunistically traded short-term volatility, doubling its stake in payments company WEX near historical forward P/E lows of 6.5x before trimming into strength, aggressively buying clinical research provider Medpace Holdings following a temporary bookings-driven selloff, and reducing long-time compounder TFI International to below 1% after share price recovery narrowed its discount to intrinsic value.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
78%
CautiousHigh
High Conviction (78%)
Portfolio construction exhibits high concentration across 30 total holdings with 52% of assets in the top 10 positions. The manager demonstrates decisive rebalancing behavior, doubling stakes in WEX at cycle valuation lows and adding 40% to Medpace during earnings dislocations. Sizing discipline is firmly executed by trimming long-term winners like TFI International below 1% as price reaches fair value.
Growth Outlook
68%
BearishBullish
Bullish (68%)
Constructive medium-term view anticipates a fundamental re-evaluation that resolves extreme valuation disparities between cash flows and mega-cap tech momentum. Market breadth expansion witnessed in July confirmed latent demand for cash-generative equities. Long-term rate normalization is viewed as structurally advantageous for disciplined corporate platform acquirers.
Risk Appetite
72%
DefensiveAggressive
Aggressive (72%)
Capital remains fully committed to fundamental equities without macro-driven hedging or defensive cash build-ups. The fund is leaning into volatility by adding platform acquirers like Patrick Industries and aggressively buying transient earnings-related drawdowns. Risk is managed via conservative balance sheets and margin of safety rather than gross exposure reductions.
Capital Deployment
65%
De-riskingDeploying
Net Neutral (65%)
Capital deployment was moderately active during the quarter, deploying cash into new platform holding Patrick Industries while taking advantage of share price weakness. Net portfolio additions were balanced by significant profit-taking in WEX and Medpace following sharp rallies, maintaining an unchanged holding count of 30 names.
Forward Guidance
75%
CautiousExpansionary
Expansionary (75%)
The manager displays an active buying bias toward cash-flow-supported businesses suffering from transient multiple compression. Portfolio guidance highlights ongoing willingness to scale positions on irrational price weakness and harvest into rapid multiple expansions. Tactical readiness remains high to exploit further broadening in market participation.
Language Signal
72%
BearishBullish
Bullish (72%)
Directional vocabulary strongly emphasizes opportunities, margin of safety, coiled-spring dynamics, intrinsic value, and earnings growth. References to headwinds, multiple compression, and tariff chaos are framed as cyclical mispricings rather than structural economic impairment. Rebound potential is characterized as swift and pronounced once sentiment rotates.
Perceived Risk
52%
Low RiskElevated
Moderate Risk (52%)
Macroeconomic risks are recognized, particularly trade policy friction and tariff escalations between the U.S. and Canada alongside elevated interest rates. However, systemic alarm is dismissed, with 5% yields contextualized as historical normality. Primary risk perception centers on multiple risk within speculative momentum themes rather than economic insolvency.
Opportunity Density
74%
ScarceAbundant
Abundant (74%)
Substantial opportunity set is identified among mid-cap platform compounders whose valuations detached from underlying business progress during mega-cap speculative runs. Private equity retreat due to higher borrowing costs expands the pipeline for accretive corporate tuck-ins. Volatility in high-quality names like Medpace and WEX generates frequent mispriced entry points.
Time Horizon
82%
Short-TermLong-Term
Decade+ (82%)
The strategy maintains a multi-year compounding horizon anchored by historical precedent, as evidenced by holding TFI International continuously for two decades. The manager explicitly rejects chasing short-term narratives at peak multiples, committing to position ahead of cycle turns. Portfolios are constructed to capture fundamental re-evaluations unfolding over multi-year business cycles.